Follow-up Study of AAV-Mediated Gene Transfer (UX111; Previously Known as ABO-102) for MPS Type IIIA
Trial details
- Registry ID
- NCT04360265
- Phase
- Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Follow-up Study of AAV-Mediated Gene Transfer (UX111; Previously Known as ABO-102) for MPS Type IIIANCT04360265 | RARE | Phase 3 | Enrolling by invitation | 2027-08Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |